在新生儿重症监护病房使用低剂量多巴胺
Mallory A Prideaux1, Ronnie Guillet1
1Division of Neonatology, Golisano Children's Hospital, University of Rochester, Rochester, NY.
NeoReviews
|March 31, 2024
概括
低剂量的多巴胺被广泛用于新生儿急性损伤 (AKI),尽管缺乏证据表明它有好处,但却会引起不良影响,特别是在早产婴儿身上. 本审查审查了当前关于其在新生儿中使用的知识.
科学领域:
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 多巴胺几十年来一直用于治疗低血压,理论上可以预防儿科患者的急性损伤 (AKI).
- 脏多巴胺受体的激活会增加尿液输出,但缺乏证据表明低剂量的多巴胺可以预防AKI,透析或死亡.
- 多巴胺使用与不良影响有关,特别是在早产婴儿中.
结论:
- 目前的证据不支持在新生儿中常规使用低剂量多巴胺来预防或治疗AKI.
- 新生儿科医生应该重新考虑使用低剂量的多巴胺,因为缺乏证明的益处和潜在的危害.
- 需要进一步的研究来确定多巴胺在新生儿病学中的真正作用,如果有的话.
更多相关视频
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
85.9K
05:45Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures
Published on: November 2, 2015
7.3K
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
313
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
313
